Podcast
 |
| Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillBurrill Conferences
Life Sciences Conferences
The Indiana Life Sciences Forum
Agenda
Monday, October 19, 2009
*times and speakers subject to change
6:00 – 8:00 pm
Eli Lilly & Company and Cook Group Incorporated
Indiana Life Sciences Forum Kick Off Reception
Tuesday, October 20, 2009
7:45 – 8:30 am
Registration & Continental Breakfast
8:30 – 9:45 am
Life Sciences: State-of-the-Industry/ Navigating the Sea Change
G. Steven Burrill, CEO, Burrill & Company (Confirmed)
9:45 – 10:00 am
Coffee Break
10:00 – 11:00 am
Panel: Big Pharma – What are the Big Pharmas going to look like and what does that mean for the rest of us?
11:00 am – 12:00 pm
Panel: BioGreentech
- Katherine Armstrong, Global Trait Product Development R&D Leader, Dow AgroSciences (Confirmed)
- Marshall Martin, Associate Director of Agricultural Research Programs and Professor of Agricultural Economics, Purdue University (Confirmed)
- Maureen McCann, PhD, Assoc. Professor and Assistant Head, Biological Sciences & Director for Energy Frontiers Resources Center (Confirmed)
Moderated by: John Hamer, Managing Director, Burrill & Company (Confirmed)
12:00 – 1:00 pm
Lunch
1:00 – 1:30 pm
State of the Life Sciences/Indiana
Presentation of the Life Sciences’ Champion of the Year Award
David Johnson, President & CEO, BioCrossroads (Confirmed)
Panel: The Cost of Care and Healthcare Reform
- Cheryl Blanchard, SVP, R&D, Zimmer (Confirmed)
- Dan Peterson, Vice President Industry & Government Affairs, Cook Group Incorporated (Confirmed)
- Luis T. Gutierrez, Jr, President, Covance Periapproval & Market Access Services, Covance (Confirmed)
- Vince Ventimiglia, SVP, Baker & Daniels Consulting, Heath and Life Sciences Practice & Former HHS Assistant Secretary (Confirmed)
Moderated by: David Johnson, President & CEO, BioCrossroads (Confirmed)
2:30 – 2:45 pm
Break
2:45 – 4:00 pm
Panel: Update on capital availability for Indiana Companies
- Mike Arpey, Managing Director, Credit Suisse (Confirmed)
- John Hamer, Managing Director, Burrill & Company (Confirmed)
- Ron Meeusen, Managing Partner, Midpoint Ventures (Confirmed)
- Art Pappas, Managing Partner, Pappas Ventures (Confirmed)
- Mitchell Roob, CEO of the Indiana Economic Development Corporation and Secretary of Commerce for the State of Indiana (Confirmed)
Moderated by: G. Steven Burrill, CEO, Burrill & Company (Confirmed)
4:00 pm
Closing Remarks
G. Steven Burrill, CEO, Burrill & Company (Confirmed)